In some cancers, when p53 mutates and ceases to function as a tumor suppressor, it also aggregates into prion-like forms that then affect wild-type p53.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
Christie Rizk is an assistant editor at Genome Technology.